Literature DB >> 18661143

A 5-year follow-up of photocoagulation in diabetic macular edema: the prognostic value of vascular leakage for visual loss.

Birgit Sander1, Per Hamann, Michael Larsen.   

Abstract

AIM: To study the long-term visual result of photocoagulation of clinically significant macular edema (CSME) in diabetic patients in relation to baseline retinal vascular leakage assessed by vitreous fluorometry.
METHODS: The study enrolled 36 eyes in 27 diabetic patients with CSME at baseline, all subsequently treated by photocoagulation. The diagnosis of CSME and treatment procedure followed the ETDRS criteria. The leakage through the retinal vessels was calculated as the blood-retinal barrier permeability. Five years after initial photocoagulation the patients were reexamined.
RESULTS: The mean visual acuity decreased with 16 letters at follow-up, and in 15 eyes visual loss was substantial, with a decrease of 15 letters or more, corresponding to at least 3 lines. The baseline permeability was significantly higher in eyes with substantial visual loss than in eyes with more stable vision (14.2 nm/sec and 6.3 nm/sec respectively; p = 0.006), the corresponding odds ratio was 16.1 (95% CI: 1.8-146; p = 0.014). The level of retinopathy was significantly correlated to visual loss (Fisher's exact test < 0.02).
CONCLUSION: Visual acuity decreased at follow-up, and a substantial visual loss of 3 or more lines in CSME was associated with higher retinal vascular leakage at baseline with an odds ratio of 16.1. For this relatively small sample, neither diabetes duration, age or HbA(1c) reached statistical significance, indicating that blood-retinal barrier permability is a strong predictor of the visual outcome. The results support the investigation of triamcinolone or VEGF inhibition in patients with severe leakage, and may help to identify patients in need for intravitreal injection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18661143     DOI: 10.1007/s00417-008-0892-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  21 in total

1.  Progression of diabetic macular edema: correlation with blood retinal barrier permeability, retinal thickness, and retinal vessel diameter.

Authors:  Birgit Sander; Dorte Nellemann Thornit; Lotte Colmorn; Charlotte Strøm; Aniz Girach; Larry D Hubbard; Henrik Lund-Andersen; Michael Larsen
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-09       Impact factor: 4.799

2.  Diabetic macular edema: passive and active transport of fluorescein through the blood-retina barrier.

Authors:  B Sander; M Larsen; B Moldow; H Lund-Andersen
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-02       Impact factor: 4.799

3.  Effects of acetazolamide on passive and active transport of fluorescein across the normal BRB.

Authors:  B Moldow; B Sander; M Larsen; H Lund-Andersen
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-07       Impact factor: 4.799

4.  Analysis of the blood-retinal barrier: its relation to clinical and metabolic factors and progression to retinopathy in juvenile diabetics. A 4-year follow-up study.

Authors:  A Castillo; J M Benitez del Castillo; D Diaz; O Sayagues; J L Ruibal; J Garcia-Sanchez
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-04       Impact factor: 3.117

5.  Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

6.  Diabetic macular oedema: the effect of photocoagulation on fluorescein transport across the blood-retinal barrier.

Authors:  B Sander; M Larsen; C Engler; B Moldow; H Lund-Andersen
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

7.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes.

Authors:  R Klein; B E Klein; S E Moss; K J Cruickshanks
Journal:  Ophthalmology       Date:  1998-10       Impact factor: 12.079

8.  The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema.

Authors:  R Klein; B E Klein; S E Moss; M D Davis; D L DeMets
Journal:  Ophthalmology       Date:  1984-12       Impact factor: 12.079

9.  Early changes in diabetic retinopathy: capillary loss and blood-retina barrier permeability in relation to metabolic control.

Authors:  B Sander; M Larsen; C Engler; H Lund-Andersen; H H Parving
Journal:  Acta Ophthalmol (Copenh)       Date:  1994-10

10.  Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study.

Authors:  E Chew; S Strauber; R Beck; L P Aiello; A Antoszyk; N Bressler; D Browning; R Danis; J Fan; C Flaxel; S Friedman; A Glassman; C Kollman; H Lazarus
Journal:  Ophthalmology       Date:  2007-06       Impact factor: 12.079

View more
  2 in total

1.  Effects of intravitreal conbercept before panretinal photocoagulation on lipid exudates in diabetic macular documented by optical coherence tomography.

Authors:  Jing-Rong Shi; Quan Zhang; Ting Zhang; Hong Zhuang; Zhong-Cui Sun; Yao-Wu Qin
Journal:  Int J Ophthalmol       Date:  2020-04-18       Impact factor: 1.779

2.  Impact of changes in metabolic control on progression to photocoagulation for clinically significant macular oedema: a 20 year study of type 1 diabetes.

Authors:  B Sander; M Larsen; E W Andersen; H Lund-Andersen
Journal:  Diabetologia       Date:  2013-08-30       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.